This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
Gaining a higher level of visibility into pharmaceutical supply chains is essential as the portion of pharmaceutical products sensitive to temperature, vibration, humidity or timing is growing at approximately twice the rate of non-cold chain products.
The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs.
Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.
In the ever-evolving landscape of pharmaceuticals, innovation has become a guiding force for companies toward a future where healthcare is not only effective but seamlessly integrated into our daily lives. The company envisions a future where connected devices enhance patient care and pharmaceutical packaging simultaneously.
The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.
Data collection is no new concept for the pharmaceutical supply chain –– but is it the right data? Undetected in-transit issues in the cold chain can cost companies billions of dollars in lost revenue. And is it being used properly?
Medical and pharmaceutical manufacturers have faced increasing logistical challenges over the past two years. Amid significant regulatory and compliance changes around the world, they've had to contend with massive supply chain disruptions caused by the pandemic. Increasing demand for specific products is also causing supply chain shortages.
Uber Health announced today it’s expanding to include pharmaceutical delivery through a partnership with on-demand digital-prescription platform NimbleRx. The partnership is beginning in Seattle and Dallas, but Uber said it “plans to grow in the coming months” to include more medication deliveries to those who need it.
The pharmaceutical industry is growing exponentially, and products that are sensitive to temperature, vibration, humidity, and/or timing are growing at twice the rate of non-cold chain products.
There has been a rise in pharmaceutical, medical device and digital therapeutics companies investing in telehealth. It works with these pharmaceutical, medical device and digital therapeutics companies to help people access treatment through telemedicine.
In today’s rapidly evolving healthcare landscape, pharmaceutical companies are increasingly adopting innovative models to stay competitive. At the intersection of traditional pharmaceutical industry practices and modern digital solutions stands a promising strategy: blending in-house expertise with external partnerships with startups.
In this article, produced in partnership with Connected Health Pulse, we explore five critical challenges in pharmaceutical supply chains caused by a lack of visibility. Failure is measured in lost revenue, reputation, and potentially patient lives.
A new report from PwC predicts that new and proposed FDA regulations could open up doors for pharmaceutical companies looking to develop digital tools.
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund and Teva Pharmaceuticals, as well as tech company Amazon Web Services, is currently accepting new applicants for its new challenge.
They will later offer the enhanced digital pathology platform to pharmaceutical and biotechnology companies and academic institutions. In a statement, NEC said it will work with Biomy in enhancing the latter's cloud-based automated digital pathology analytical platform DeepPathFinder to discover new pathological biomarkers.
Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.
At the Frontiers Health conference, Eloise McLennan , Deep Dive editor at pharmaphorum, interviewed Fabrizio Connicella , Vice-President Center of Open Innovation & Competence at Chiesi Farmaceutici SpA , to discuss the evolving landscape of pharmaceutical innovation. “ We stand at a pivotal moment for the pharmaceutical industry.
The Silicon Valley EHR vendor received “sponsorship” payments from unnamed pharmaceutical companies so that the latter’s marketing team could influence the design of CDS features, according to the Department of Justice.
The pharmaceutical industry and health insurance companies garnered 3 in 10 people rating them as excellent/good, with nursing homes at the bottom a 2.5/10 10 – or 4 in 10 ranking as “poor.” health system.
While this program has been instrumental in making medications more affordable for many, there is a significant challenge that patients enrolled in Medicare Part D face – the inability to take advantage of pharmaceutical coupon programs offered by drug manufacturers to reduce medication costs. Again, how might we fix this?
The need to accelerate virtual trials is just one takeout that Henry Levy, GM at Veeva Vault CDMS, talks about in an exclusive interview with MobiHealthNews, in which the impact of COVID-19 on the pharmaceutical industry is addressed.
The European Federation of Pharmaceutical Industries and Associations and researchers across Europe teamed up on a €50 million project to develop a wearable sensor of clinical trials.
The main areas of use of biotechnology today are medicine, pharmaceuticals, agriculture, and other industries, where BioTech innovations can reduce the cost of production, speed up the development of vaccines, or model the changes of […]. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited.
During an afternoon roundtable session held yesterday at BIO 2018 in Boston, a panel of digital medicine and pharmaceutical representatives discussed the impact that these novel medicines has had, and could have, on drugmakers, regulators, and those prescribing the medications.
Australia-based healthcare analytics startup Prospection has announced the opening of its Japan headquarters, and appointment of health informatics and pharmaceutical veteran Kaoru Sato to lead the company’s first global office.
Simplifying Complexity with AI Drug pricing and access are increasingly difficult to navigate, with healthcare payers and pharmaceutical companies facing inefficiencies, missed opportunities, and delays in delivering therapies to patients. About Lyfegen Lyfegen is a global provider of market access, pricing, and rebate management solutions.
The pharmaceutical industry is constantly evolving, driven by advances in science, technology, and patient needs. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. One of the most prominent trends shaping this industry is the outsourcing of various stages of drug development.
Bormioli Pharma has a portfolio of pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems that is complementary to Gerresheimer. The company manufactures pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems.
While there has been a big focus on pharmaceutical companies and their sky-high prices in the media, including previously […]. Illegal copying is prohibited. According to Statista, in 2019, U.S. drug store and pharmacy sales totaled nearly 297 billion dollars.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content